Slocum, Gordon & Co’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Buy
3,807
+7
+0.2% +$639 0.23% 49
2026
Q1
$390K Sell
3,800
-450
-11% -$50.8K 0.27% 45
2025
Q4
$532K Hold
4,250
0.39% 45
2025
Q3
$569K Hold
4,250
0.45% 41
2025
Q2
$578K Hold
4,250
0.47% 36
2025
Q1
$564K Hold
4,250
0.42% 36
2024
Q4
$481K Hold
4,250
0.4% 39
2024
Q3
$485K Hold
4,250
0.19% 41
2024
Q2
$442K Hold
4,250
0.33% 39
2024
Q1
$483K Sell
4,250
-450
-10% -$51.6K 0.36% 36
2023
Q4
$517K Buy
+4,700
New +$470K 0.45% 34
2023
Q3
Sell
-4,700
Closed -$512K 147
2023
Q2
$512K Hold
4,700
0.37% 34
2023
Q1
$476K Sell
4,700
-1
-0% -$106 0.39% 34
2022
Q4
$516K Buy
+4,701
New +$487K 0.33% 35

Other funds holding ABT

Slocum, Gordon & Co's ABT Position: Q2 2026 in Review

Slocum, Gordon & Co increased its Abbott (ABT) stake by 0.18% in Q2 2026, buying an estimated $639 and bringing the position to 3,807 shares worth $345K. The position accounts for 0.23% of the portfolio, ranked #49.

Slocum, Gordon & Co first reported a position in ABT in Q4 2022 and has held it in 14 quarters since. The position peaked at $578K in Q2 2025. 1,131 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Slocum, Gordon & Co held 3,807 shares of Abbott worth $345K as of Q2 2026.
  • Slocum, Gordon & Co bought 7 Abbott shares in Q2 2026, an estimated $639.
  • Abbott made up 0.23% of Slocum, Gordon & Co's portfolio in Q2 2026, its #49 holding.
  • Slocum, Gordon & Co first reported a position in Abbott in Q4 2022 and has held it in 14 quarters since.
  • Slocum, Gordon & Co's Abbott position peaked at $578K in Q2 2025.
  • 1,131 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Slocum, Gordon & Co's 13F filing for Q2 2026, filed 23 Jul 2026.